Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $164000.0.

  • Kura Oncology's Depreciation & Amortization (CF) fell 2115.38% to $164000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $833000.0, marking a year-over-year change of. This contributed to the annual value of $848000.0 for FY2024, which is 11.78% down from last year.
  • Latest data reveals that Kura Oncology reported Depreciation & Amortization (CF) of $164000.0 as of Q3 2025, which was down 2115.38% from $224000.0 recorded in Q2 2025.
  • Kura Oncology's 5-year Depreciation & Amortization (CF) high stood at $241000.0 for Q1 2025, and its period low was $164000.0 during Q3 2025.